Oura agrees to buy medical AI startup Counsel Health for $625 million

The smart ring maker is absorbing the chatbot-and-physician service already built into its app, weeks after shelving an IPO; Oura says it expects the deal to close before the end of 2026.

StartupsPublished Updated
OURA Ring - 2
Image: Kyu3a / Wikimedia Commons, CC BY-SA 4.0, cropped · Source · Licence

Correction, . An earlier version said reports differed on when the deal would close. Oura's press release says it expects closing before the end of 2026, subject to customary closing conditions; TechCrunch's 2027 date does not match it.

What happened
Oura said it has agreed to acquire Counsel Health, an AI-driven primary care startup, for $625 million alongside its quarterly earnings.
What’s new
Counsel's service has been integrated into the Oura app since June; Oura now plans to own it outright and expand into acute and chronic care.
Why it matters
The deal would let Oura link wearable biometrics to AI medical advice and physicians, while Counsel keeps selling to outside enterprise customers.

Oura has agreed to buy Counsel Health for $625 million. The smart ring company disclosed the deal alongside its quarterly results on Tuesday. Counsel describes itself as an AI-native primary care company. Its app pairs an AI chat service, which answers medical questions using biometric data from wearables, with access to licensed physicians when a user needs one. According to TechCrunch, Oura integrated Counsel's service into its own app in June, so the purchase extends an existing partnership.

What Oura says it plans to build

The companies say they will focus on three areas. The first is preventative care. The second is acute care for episodic health concerns. The third is specialty and chronic care, with reproductive and cardiometabolic health cited as examples. Oura CEO Tom Hale told Bloomberg, as relayed by The Verge, that the goal is to connect wearables, clinical AI and access to doctors, both to answer questions and to monitor ongoing conditions.

Counsel's on-demand physician network has roughly 50 people, according to Counsel CEO Muthu Alagappan in Bloomberg's reporting. He said the company plans to grow that network. Counsel's 70 employees will move to Oura, and Alagappan will become Oura's chief clinical AI officer. In Oura's press release, quoted by TechCrunch, Alagappan said Counsel keeps physicians in the loop for clinical decisions.

Counsel will not become exclusive to Oura owners. Oura says the startup will keep offering its platform through new and existing enterprise partners. The Verge, citing Oura's announcement, lists those partners as health plans, health systems, consumer health organizations and employers.

Financial backdrop and closing timing

TechCrunch notes that the acquisition comes a few weeks after Oura indefinitely postponed an IPO of up to $2.2 billion. The company cited uncertainty in the IPO market. Oura reported preliminary, unaudited quarterly revenue of $533 million for the period ended September 30, up 153% year over year. It put revenue for fiscal 2026 at about $1.75 billion, a 92% increase. TechCrunch adds that Oura was valued at $11 billion after a $900 million funding round in October 2025.

Counsel is a much smaller company. TechCrunch reports it raised a $25 million Series A a year ago, led by Andreessen Horowitz and GV. PitchBook estimates its total funding at $36 million. In TechCrunch's assessment, Oura has long dominated the smart ring market but faces rising competition from RingConn and Ultrahuman, which pressures it to keep innovating.

Oura's press release says the $625 million is paid in cash, subject to purchase price adjustments, and that the transaction is expected to close before the end of the calendar year, subject to customary closing conditions. The Verge reports the same timing. TechCrunch's report says closing is expected before the end of 2027, which does not match Oura's release.